SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, today announced that it will hold a conference call on Tuesday, November 20, 2012 at 4:30 p.m. Eastern (1:30 p.m. Pacific) to provide an update on its business and conduct a question and answer session with investors.
Individuals interested in listening to the conference call may do so by dialing 877-407-0782, or for international callers 201-689-8567. The call will also be webcast, and can be accessed at www.InvestorCalendar.com.
An audio replay will be available through January 20, 2013 by dialing 877-660-6853, or for international callers 201-612-7415, and entering the Account #: 286, and the Conference ID #: 403900. The webcast will be available on the Company's Web site (www.spectrascience.com) and www.InvestorCalendar.com for 90 days following the completion of the call.
About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate result. With approval for sale under the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.
Contact: SpectraScience, Inc. Jim Dorst Chief Financial Officer